Britton Jimenez, SVP of Sales and Marketing at Codexis, explains how the ECO Synthesis® Manufacturing Platform overcomes the ...

As antibiotic-resistant infections rise and are projected to cause up to 10 million deaths per year by 2050, scientists are ...

CAMP4 Therapeutics Corporation ( ($CAMP) ) has provided an announcement. On December 17, 2025, CAMP4 Therapeutics entered into a strategic ...

The biotech is advancing its new lead candidate, CMP-002, while working with BioMarin on assets that engage regRNA sequences ...

Construction at the Norton site is currently underway, with the new offerings anticipated to be operational by late 2027.

Collaboration to leverage CAMP4’s RAP Platform® to accelerate development of novel antisense oligonucleotides (ASOs) for neurodegenerative and ...

Bacteria use a short RNA guide to detect viruses and activate a self-destruct mechanism that protects the wider microbial ...

A key step to deliver RNAi therapeutics to diverse cell types and tissues beyond the liver from the collaboration of ...

A tiny viral switch discovered by Israeli and American scientists could open a new front in the fight against ...

Dengue is one of the world's fastest-spreading mosquito-borne diseases, causing millions of infections annually. Half of the ...

Gestational diabetes can cause a multitude of complications in the offspring, but to date, the reasons are incompletely ...

Scientists have developed a groundbreaking \"urine aging clock\" that analyzes microRNAs to predict biological age, offering ...